Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing'

A group of U.S. senators is digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this year in search of any indication the services could create conflicts of interest for prescribers.